Relationship: Endometriosis and EPA (eicosapentaenoic acid)

Evidence supporting the use of: EPA (eicosapentaenoic acid)
For the health condition: Endometriosis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis
Other ingredients for this health condition
Other health conditions supported by this ingredient
Products containing this ingredient

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Eicosapentaenoic acid (EPA), an omega-3 polyunsaturated fatty acid found in fish oil, has been investigated for its potential role in managing endometriosis. The rationale for its use stems from EPA’s anti-inflammatory properties. Endometriosis is characterized by chronic inflammation, and omega-3 fatty acids can modulate inflammatory pathways by decreasing the synthesis of pro-inflammatory eicosanoids derived from arachidonic acid. Several small clinical studies and preclinical animal models have suggested that omega-3 supplementation, including EPA, may reduce pelvic pain and slow the progression of endometriotic lesions. For example, a 2013 randomized controlled trial (RCT) found that women who received omega-3 supplements reported a reduction in endometriosis-associated pain compared to placebo, though the study was small and included both EPA and DHA. Additionally, epidemiological data indicate that higher dietary intake of omega-3 fatty acids is associated with a reduced risk of developing endometriosis. However, the overall quality and quantity of evidence remain limited. Most clinical trials have small sample sizes, variable EPA/DHA ratios, and short durations. Systematic reviews conclude there is some promise, but larger, well-designed RCTs are needed to establish efficacy. Nonetheless, the biological plausibility and preliminary human data provide a moderate scientific basis for EPA’s use in endometriosis management, especially as an adjunct to conventional therapies.

More about EPA (eicosapentaenoic acid)
More about Endometriosis

Products containing EPA (eicosapentaenoic acid)

Health Concerns

Brands

Evidence supporting the use of: EPA (eicosapentaenoic acid)
For the health condition: Endometriosis

Table of Contents

Synopsis

Other ingredients used for Endometriosis

Other health conditions supported by EPA (eicosapentaenoic acid)

Products containing EPA (eicosapentaenoic acid)

Health Concerns

Brands

Evidence supporting the use of: EPA (eicosapentaenoic acid)For the health condition: Endometriosis

Table of Contents

Synopsis

Other ingredients used for Endometriosis

Other health conditions supported by EPA (eicosapentaenoic acid)

Products containing EPA (eicosapentaenoic acid)

Evidence supporting the use of: EPA (eicosapentaenoic acid)
For the health condition: Endometriosis